Rosalind Advisors, Inc. 13D and 13G filings for Kiora Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 1:56 pm Sale | 2025-06-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors, Inc. | 464,676 9.900% | -250,555 (-35.03%) | Filing |
| 2025-02-10 4:03 pm Purchase | 2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors, Inc. | 715,231 9.900% | 250,554 (+53.92%) | Filing |
| 2024-05-29 3:47 pm Unchanged | 2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors, Inc. | 464,677 9.900% | 0 (Unchanged) | Filing |
| 2024-05-29 3:43 pm Purchase | 2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors, Inc. | 464,677 9.900% | 464,677 (New Position) | Filing |